Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization
A man holds a swab during a coronavirus test at a temporary testing facility in West Ealing on February 2, 2021 in London, United Kingdom. (Photo by Hollie Adams/Getty Images)
(WISH) — The Food and Drug Administration has granted Emergency Use Authorization to Roche’s COVID-19 At-Home Test in an effort to expand the public’s access to rapid self-testing options, Roche announced Friday.
The test uses a nasal swab sample and provides results within 20 minutes for COVID-19 and its known variants of concern, including omicron, Roche said.
Beginning in January, the test will be available to purchase over-the-counter at pharmacies and retailers across the nation.
The company has the capacity to produce tens of millions of tests per month, Roche said.